Visceral fat explained: what it is, why it matters more than your weight, and how to measure it accurately
The fat you can see is not the fat that matters most. The fat that drives cardiovascular disease, insulin resistance, and metabolic decline sits deep inside your abdominal cavity, packed around your liver, pancreas, and intestines. You cannot pinch it. Your bathroom scale cannot detect it. Two people with identical body weight and waist measurements can have dramatically different amounts of it.
That fat is visceral fat. Research consistently shows it is a stronger predictor of metabolic disease and cardiovascular events than total body fat or BMI.
Visceral fat is one of the primary metrics the LIGHT Body Scanner measures because it reliably predicts what happens to your health over the next decade. This article explains what visceral fat is, how it behaves, what a healthy level looks like, and how to measure it accurately over time.
What is visceral fat?
Visceral fat, also called visceral adipose tissue (VAT), is stored within your abdominal cavity. It surrounds your liver, pancreas, and intestines. It is distinct from subcutaneous fat, which sits just below the skin and is visible and palpable.
Visceral fat is not passive storage. It is metabolically active tissue that continuously releases hormones, inflammatory signals, and free fatty acids directly into the portal vein, the blood supply that feeds your liver. That direct line to your liver is what makes visceral fat far more disruptive than fat stored elsewhere in your body.
Key distinction
Visceral fat is not the same as belly fat. You can have a flat stomach and carry significant visceral fat internally. Abdominal girth only loosely correlates with visceral fat volume. Accurate measurement requires body composition analysis.
Visceral fat vs subcutaneous fat
The two types of fat have fundamentally different effects on your health. Subcutaneous fat sits between your skin and the muscle wall. Excess subcutaneous fat carries health risks, but it is considerably less metabolically dangerous than visceral fat.
| Feature | Visceral fat | Subcutaneous fat |
|---|---|---|
| Location | Surrounds internal organs | Under the skin |
| Visible? | No | Yes (pinchable) |
| Metabolic activity | Very high | Moderate |
| Inflammatory cytokine release | High | Low to moderate |
| Free fatty acid release | Directly to liver via portal vein | Systemic circulation |
| Link to insulin resistance | Strong | Weak to moderate |
| Responds to exercise | Yes, faster than subcutaneous | Yes, slower |
| Detectable by scale or tape measure | No | Partially |
Subcutaneous fat can serve a protective function when visceral fat is low. Problems develop when visceral fat accumulates, shifting the metabolic balance toward inflammation, insulin resistance, and elevated cardiovascular risk. That shift happens regardless of how much subcutaneous fat is present.
What visceral fat does to your body
Visceral fat functions like an endocrine organ. Studies show it continuously releases pro-inflammatory cytokines, including interleukin-6 and tumour necrosis factor-alpha, as well as adipokines that impair insulin signalling in your liver and muscle. As visceral fat expands, this biochemical output increases. The result is a systemic low-grade inflammatory state that underlies most chronic metabolic disease.
The portal circulation is the central mechanism. Free fatty acids released by visceral fat drain directly into the portal vein and reach your liver before entering the general bloodstream. That concentrated exposure impairs hepatic insulin clearance, promotes triglyceride synthesis, and drives the atherogenic dyslipidaemia pattern: elevated LDL, elevated triglycerides, and reduced HDL.
Important
You can have a normal BMI and dangerously elevated visceral fat. This is sometimes called metabolically obese normal weight, or "skinny fat." Visceral fat is the primary driver of type 2 diabetes risk independent of your total body weight.
Visceral fat and your heart
A 2024 review analysing 27 observational studies found that a higher visceral-to-subcutaneous fat ratio is consistently associated with hypertension, atherosclerosis, coronary heart disease, and heart failure. A 2025 cohort study found that cumulative visceral fat exposure tracked over time independently predicts both cardiovascular events and all-cause mortality.
The mechanism goes beyond raised LDL. Inflammatory cytokines released by visceral fat damage endothelial cells, promote plaque formation, and accelerate arterial stiffening. One 2024 analysis established a visceral fat area of 100 cm² on CT as a clinical threshold for elevated cardiometabolic risk.
Visceral fat and type 2 diabetes
Visceral fat is the primary driver of insulin resistance in most adults, outweighing total body fat as a predictor. A 2024 review in the journal Nutrients summarised the mechanism: visceral adipose tissue has a higher rate of lipolysis than subcutaneous fat, releases free fatty acids directly into the portal circulation, and causes your liver to produce more glucose while clearing less insulin. Over time, that drives hyperinsulinaemia and pancreatic beta-cell exhaustion.
Two people with the same BMI can have very different visceral fat loads, and their diabetes risk tracks with visceral fat, not BMI. That is the core problem with using body weight or waist circumference as a proxy for metabolic risk. They are imprecise. A direct measurement of visceral fat is not.
Clinical insight
Both the absolute amount of visceral fat at baseline and increases over time are strongly linked to type 2 diabetes incidence. Tracking the direction of change, not just the static number, is what matters for early intervention.
What are healthy visceral fat levels?
Reference values depend on measurement method, age, and sex. DEXA-based measurements report visceral fat in kilograms or grams. CT and MRI report visceral fat area in cm². Consumer BIA devices use unitless rating scales that are not comparable to clinical measurements.
Men carry roughly twice the visceral fat mass of women at the same age. Both sexes see visceral fat increase progressively from the third decade. Men accelerate faster in midlife as testosterone declines. Women catch up after menopause as oestrogen's protective effect fades.
| Age group | Men — low risk (kg) | Men — elevated risk (kg) | Women — low risk (kg) | Women — elevated risk (kg) |
|---|---|---|---|---|
| 20–39 | < 0.9 | > 1.2 | < 0.5 | > 0.8 |
| 40–59 | < 1.5 | > 2.0 | < 0.8 | > 1.0 |
| 60+ | < 2.0 | > 2.5 | < 1.2 | > 1.5 |
Reference values derived from DXA-based population cohorts including the Copenhagen City Heart Study and the Austrian LEAD cohort. Thresholds vary by measurement method and ethnicity. For individuals of East Asian background, risk thresholds are approximately 20 to 25% lower. Consult a clinician for personalised interpretation.
How visceral fat is measured
Most people have no reliable way to track their visceral fat. That gap matters more than most people realise. What you cannot measure, you cannot manage.
CT and MRI are the gold standard, producing precise cross-sectional images of fat distribution. Both are highly accurate. CT involves radiation exposure, and both methods cost hundreds to thousands of dollars. Neither is practical for routine monitoring.
DEXA scanning is the clinical standard for accessible measurement. It provides reliable quantification in kilograms with good validation against CT. A DEXA scan costs roughly $50 to $150 out of pocket and requires a clinic visit. It works well for a baseline, but it is not designed for frequent monitoring.
Waist circumference above 40 inches in men and 35 inches in women signals elevated risk. It is a useful screening tool, but research shows it cannot distinguish between subcutaneous abdominal fat and visceral fat. Two people with the same waist measurement can have visceral fat levels that differ by a factor of three.
Standard BIA scales estimate visceral fat using a rating scale, but accuracy is limited by electrode count, signal frequency, and hydration status. They detect large changes but lack the sensitivity to track gradual shifts. To understand how these options compare in practice, the table below covers the options available to you today.
| Method | Accuracy | At home? | Cost | Practical for tracking? |
|---|---|---|---|---|
| CT scan | Gold standard | No | $500–$2,000+ | No |
| MRI | Gold standard | No | $1,000–$3,000+ | No |
| DEXA scan | High | No | $50–$150 | Quarterly at best |
| Waist circumference | Low | Yes | Free | Yes, crude proxy only |
| Consumer BIA scale | Low to moderate | Yes | $30–$200 | Partially |
| LIGHT body scanner | 98% vs DEXA | Yes | Device cost only | Yes |
How to reduce visceral fat
Visceral fat responds to lifestyle intervention faster than subcutaneous fat. Because it is more metabolically active and receives richer blood flow, it mobilises more readily. That is worth knowing: the fat most harmful to your health is also the most responsive to change.
Exercise
A 2024 meta-analysis of 84 randomised controlled trials found that aerobic exercise, resistance training, combined training, and HIIT all significantly reduce visceral fat. The relationship is dose-dependent: more energy expended means more visceral fat lost. One analysis found that exercise produced twice the visceral fat reduction of calorie-restricted diets matched for the same energy deficit.
Diet
A moderate caloric deficit of 15 to 25 percent, delivered through whole foods, consistently reduces visceral fat while preserving muscle mass. Protein intake of 1.6 to 2.2 grams per kilogram supports lean mass retention. Ultra-processed foods and refined carbohydrates drive visceral fat accumulation independently of total caloric intake, through their direct effect on insulin and cortisol.
Sleep and stress
Chronically elevated cortisol, from poor sleep or psychological stress, preferentially promotes visceral fat deposition. Sleeping less than 6 hours per night consistently predicts higher visceral fat volume across population studies. In metabolic terms, sleep quality is one of the most underrated visceral fat interventions available to you.
Tracking progress
Visceral fat reduction is not visible in the mirror and only loosely reflected on a scale. Without a direct measurement, you can abandon interventions that are working simply because you cannot see the progress. Regular measurement is what separates deliberate fat loss from guessing. The LIGHT Body Scanner was built to solve exactly this problem.
How LIGHT measures visceral fat at home
LIGHT is a clinical-grade home body scanner using Deep Signal Imaging technology, validated at 98% accuracy against clinical DEXA scans. It measures visceral fat mass, subcutaneous fat, skeletal muscle mass, and total body water in a single 30-second scan from home.
Unlike DEXA, it requires no clinic visit. Unlike consumer BIA scales, it uses a tomographic signal model rather than a single-frequency impedance estimate, giving it the sensitivity to detect gradual changes in visceral fat over weeks rather than months. If you are managing metabolic health, tracking body recomposition, or simply want to know whether what you are doing is working, LIGHT gives you the measurement resolution that makes the difference between knowing and guessing.
Clinical references
- Emamat H, Jamshidi A, Farhadi A, et al. The association between the visceral to subcutaneous abdominal fat ratio and the risk of cardiovascular diseases: a systematic review. BMC Public Health. 2024. doi:10.1186/s12889-024-19358-0
- Liu Q, Cui H, Si F, et al. Association of cumulative exposure to metabolic score for visceral fat with the risk of cardiovascular disease and all-cause mortality. Journal of Cachexia, Sarcopenia and Muscle. 2025. doi:10.1002/jcsm.13702
- Jia S, Huo X, Zuo X, et al. Association of metabolic score for visceral fat with all-cause mortality, cardiovascular mortality, and cancer mortality. Diabetes, Obesity and Metabolism. 2024;26(12):5870-5881. doi:10.1111/dom.15959
- Stefan N, Häring HU, Schulze MB. Fat distribution patterns and future type 2 diabetes. Diabetes. 2022;71(9):1937-1941. doi:10.2337/dbi22-0008
- Coelho M, Oliveira T, Fernandes R. Visceral adipose tissue: the hidden culprit for type 2 diabetes. Nutrients. 2024;16(7):1015. doi:10.3390/nu16071015
- Baarts C, Suetta C, et al. Age- and sex-specific changes in visceral fat mass throughout the life-span. Obesity. 2023. doi:10.1002/oby.23779
- Swainson MG, Batterham AM, Hind K. Age- and sex-specific reference intervals for visceral fat mass in adults. International Journal of Obesity. 2019;44:289-296. doi:10.1038/s41366-019-0465-5
- Chen X, et al. Effects of various exercise types on visceral adipose tissue in individuals with overweight and obesity: a systematic review and network meta-analysis of 84 randomised controlled trials. Obesity Reviews. 2024;25(3):e13666. doi:10.1111/obr.13666
- Verheggen RJ, Maessen MF, Green DJ, et al. A systematic review and meta-analysis on the effects of exercise training versus hypocaloric diet. Obesity Reviews. 2016;17(8):664-690. doi:10.1111/obr.12406
- Miazgowski T, et al. Visceral fat reference values derived from healthy European men and women aged 20-30 years using GE Healthcare dual-energy x-ray absorptiometry. PLOS ONE. 2017;12:e0180614. doi:10.1371/journal.pone.0180614
Common questions about visceral fat
Measure what a scale cannot
LIGHT measures visceral fat, muscle mass, and body composition from home — with 98% accuracy against a clinical DEXA scan.

